
About Biosilt Pharmaceutical India Private Limited
Data last updated:
Biosilt Pharmaceutical India Private Limited is a private limited company based in Saidulajaib, Delhi, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 20 July 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U74999DL2018PTC336800. Its GSTIN is 07AAHCB9302J1ZM (Delhi).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Vikash Kumar Sah and Pushpa.
Its last annual general meeting (AGM) was held on 30 September 2023, and its latest financial statements are for the year ended 31 March 2023. The registered office is at Khasra No – 357/302 D – 4 B/S Third Floor, Saidulajaib, Delhi, India – 110030.
As per the financials filed for FY 2023, the company reported a revenue of ₹4.61 Lakh, reflecting significant growth compared to the previous year. For the same year it recorded a net loss of ₹43,479 (net margin -9.4%) and EBITDA of -₹38,792 (EBITDA margin -8.4%). Revenue has declined at a compounded annual rate (CAGR) of 14% over three years.
The company is associated with 1 brand: Biosilt.
For more details, the company can be reached via its website biosilt.com.
Company details
Contact details
Biosilt Pharmaceutical India Private Limited's registered office is in Saidulajaib, Delhi. Its website is biosilt.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressKhasra No – 357/302 D – 4 B/S Third Floor, Saidulajaib, Delhi, India – 110030
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Biosilt Pharmaceutical India Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Biosilt Pharmaceutical India operates one associated brand: Biosilt. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Offers pharma marketing, promotional inputs, and training for companies across India. | biosilt.com |
Business activity
The main business activity of Biosilt Pharmaceutical India is trade. In detail, this covers retail trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G2 | Retail Trading |
To see the full business activity and turnover split of Biosilt Pharmaceutical India Private Limited, buy the company report.
Financials of Biosilt Pharmaceutical India Private Limited
FY 2023 filings availableBiosilt Pharmaceutical India Private Limited reported revenue of ₹4.61 Lakh (up 545% YoY) for FY 2023.
Compounded Annual Growth Rate (CAGR)
Revenue rose 545% in the latest year, though over three years it has declined at a compounded annual rate (CAGR) of 14%. EBITDA rose 62% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹38,792 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹43,479 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -8.4% | ||||
| Net Profit Margin | -9.4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Biosilt Pharmaceutical India Private Limited, buy the company report.
Board of directors of Biosilt Pharmaceutical India Private Limited
Biosilt Pharmaceutical India has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Vikash Kumar Sah | Director | 20 Jul 2018 | 8 Years 3 Months | Current |
| Pushpa | Director | 20 Jul 2018 | 8 Years 3 Months | Current |
Peer comparison
Biosilt Pharmaceutical India Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (retail trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Razzle Creation India Private Limited | ₹4.61 Lakh (FY 2023) | -67.0% | Ghaziabad, Uttar Pradesh, India | |||
| Unify Concepts Consultancy Private Limited | ₹4.61 Lakh (FY 2021) | -78.0% | New Delhi, Delhi, India | |||
| Statheros Healthcare Private Limited | ₹4.61 Lakh (FY 2025) | 167.0% | Kundara, Kerala, India | |||
| Invishield India Private Limited | ₹4.61 Lakh (FY 2025) | -35.0% | Pune, Maharashtra, India | |||
| Ganga Finvest Private Limited | ₹4.61 Lakh (FY 2019) | -64.0% | Delhi, India | |||
| Biosilt Pharmaceutical India Private Limitedthis company | ₹4.61 Lakh (FY 2023) | -₹43,479 | -9.4% | 545.0% | Saidulajaib, Delhi, India | |
| Bhumikisan Agrotech Private Limited | ₹4.61 Lakh (FY 2024) | 60.0% | Midnapore, West Bengal, India | |||
| Vepla Naturals Private Limited | ₹4.61 Lakh (FY 2025) | -56.0% | Thrissur, Kerala, India | |||
| Light Womenergy Private Limited | ₹4.61 Lakh (FY 2021) | -52.0% | Hyderabad, Telangana, India | |||
| Uniplus Retail Private Limited | ₹4.61 Lakh (FY 2023) | -2.0% | Cuttack, Odisha, India | |||
| Saivishwarupi Marketing Private Limited | ₹4.61 Lakh (FY 2021) | Mangalore, Karnataka, India |
To see the full peer comparison of Biosilt Pharmaceutical India Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Biosilt Pharmaceutical India Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Biosilt Pharmaceutical India Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Biosilt Pharmaceutical India has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AAHCB9302J1ZM | Delhi | Active | 24 Aug 2018 |
To see the full GST registrations and return filing status of Biosilt Pharmaceutical India Private Limited, buy the company report.
Recent activity
Biosilt Pharmaceutical India Private Limited has 2 board changes on record since 2018: 2 appointments. The latest: Pushpa was appointed as Director on 20 Jul 2018.
Frequently asked questions
Biosilt Pharmaceutical India is an active private limited company based in Saidulajaib, Delhi, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 20 July 2018 (8+ years old) and is registered under CIN U74999DL2018PTC336800.
Biosilt Pharmaceutical India has 2 current directors:
- Vikash Kumar Sah - Director
- Pushpa - Director
The latest financial statements of Biosilt Pharmaceutical India on record with the MCA are for the year ended 31 March 2023. Its last annual general meeting was held on 30 September 2023. Year-wise statements from FY 2019 are in the company report.
The GSTIN of Biosilt Pharmaceutical India is 07AAHCB9302J1ZM, registered in Delhi.
The CIN (Corporate Identification Number) of Biosilt Pharmaceutical India is U74999DL2018PTC336800. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Biosilt Pharmaceutical India was incorporated on 20 July 2018, making it 8+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Biosilt Pharmaceutical India by revenue are Razzle Creation India Private Limited, Unify Concepts Consultancy Private Limited, Statheros Healthcare Private Limited, Invishield India Private Limited, Ganga Finvest Private Limited and 5 more, all in the same principal business activity (retail trading).
Pushpa was appointed as Director on 20 Jul 2018. Vikash Kumar Sah was appointed as Director on 20 Jul 2018.
Biosilt Pharmaceutical India can be reached through the website biosilt.com. Its registered office is in Saidulajaib, Delhi, India.
The registered office of Biosilt Pharmaceutical India is at Khasra No – 357302 D – 4 BS Third Floor, Saidulajaib, Delhi, India – 110030.
Biosilt Pharmaceutical India operates in the pharma industry, in the pharmaceutical retailers and distributors segment.

